文献速递炎症性肠病消化内镜

超声评估抗TNF治疗克罗恩病应答与长期结局相关

Response Assessed by Ultrasonography as Target of Biological Treatment for Crohn's Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-12-20

该观察性研究纳入80例接受抗TNF治疗至少1年的克罗恩病患者,系列小肠超声造影(SICUS)评估应答。中位18个月时完全应答36例(51%)、部分应答30例(34%)、无应答13例(15%)。完全应答者长期手术、住院及激素需求均低于部分或无应答者。

要点

  • SICUS评估完全应答者1年内无手术,部分或无应答者手术风险更高。
  • 完全应答者激素用量及住院次数显著少于部分或无应答者。
  • 长期随访中完全应答者手术、住院及激素需求累积概率更低。

核心结论

  • 克罗恩病患者抗TNF治疗应答经SICUS评估,完全应答者长期结局优于部分或无应答者。

研究设计与样本

  • 意大利罗马大学观察性研究,纳入80例接受抗TNF治疗至少1年的克罗恩病患者。
  • 入组需有治疗前及18个月后随访SICUS,第二次SICUS时将患者分为完全应答、部分应答或无应答。

主要发现

  • 中位18个月时,完全应答36例(51%)、部分应答30例(34%)、无应答13例(15%)。

临床怎么用

  • SICUS可作为克罗恩病抗TNF治疗应答的相对无创监测方法。
  • 超声评估完全应答与长期良好结局相关,可辅助治疗决策。

局限性

  • 样本量80例,为单中心观察性研究。
  • 部分应答与无应答亚组样本量较小(30例与13例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Mucosal healing, determined by ileocolonoscopy, is a goal for treatment of Crohn's disease (CD), but this is an invasive assessment procedure. We investigated whether response to tumor necrosis factor (TNF) antagonists, determined by small-intestine contrast ultrasonography, associates with long-term outcomes. METHODS: We performed observational study of 80 patients with CD treated with anti-TNF agents for at least 1 year who underwent serial small intestine contrast ultrasonography (SICUS) at the University of Rome, in Italy. SICUS was used to evaluate disease site (based on bowel wall thickness), extent of lesions, and presence of complications. Inclusion criteria required pre-therapy SICUS with follow-up SICUS after 18 months. At second SICUS, patients were assigned to categories of complete or partial responder or non-responder. CD-related outcomes (corticosteroid need, hospitalization, and surgery) were assessed at 1 year from the second SICUS, using multivariate models, and were analyzed after long term follow up (5 years) using Kaplan-Meier survival analysis. RESULTS: Based on SICUS, after a median of 18 months, 36 patients (51%) were complete responders, 30 were partial responders (34%), and 13 were non-responders (15%). At 1 year from the second SICUS, no patients with a complete response, based on ultrasonography, underwent surgery, in comparison to partial responders (P = .0003) or non-responders (P = .001). Complete responders used smaller amounts of corticosteroids than partial responders (P = .0001) or non-responders (P < .0001). Complete responders required fewer hospitalizations than non-responders (P = .001). Kaplan-Meier survival analysis of long-term follow up data demonstrated a lower cumulative probability of need for surgery, hospitalization, and need for steroids among SICUS-categorized complete responders (P < .0001, P = .003 and P = .0001 respectively) than SICUS-categorized non-responders. CONCLUSIONS: In patients with CD, response to anti-TNF agents, determined by SICUS, is associated with better long-term outcomes than partial or no response. Ultrasonographic assessment therefore provides a relatively non-invasive method for monitoring response to treatment in patients with CD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Zorzi F, Ghosh S, Chiaramonte C, et al. Response Assessed by Ultrasonography as Target of Biological Treatment for Crohn's Disease. Clin Gastroenterol Hepatol. 2019. PMID: 31866561. doi:10.1016/j.cgh.2019.10.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。